Dear Reader,
Big Pharma is on the cusp of annihilation.
The dominance of behemoth pharmaceutical companies is about to come to an abrupt halt.
You see, while thousands of biotech companies have been shooting for billion-dollar drugs … vaccinations … and medical devices …
|
|
An innovative Midwestern firm has taken a much different route.
It is reinventing healthcare from the nucleus up … and will soon dominate this $1.7 trillion industry.
|
|
The dean of Stanford’s School of Medicine says: “The opportunities are enormous” … vice chair at Duke University’s Department of Surgery declares this is “changing the game” … and a University of Pennsylvania Wharton School of Business study calls this breakthrough “a revolutionary approach to tackling disease.”
And early investors will have the opportunity to make an absolute fortune.
Full details are here…
|
|
|
Jeff Yastine
Editorial Director, Banyan Hill Publishing
|
|
